- Transcriptomics, the study of RNA transcripts, is becoming an increasingly vital component of modern life sciences and precision medicine due to its ability to provide deep insights into gene expression, regulatory mechanisms, and disease pathways across various biological systems
- The escalating demand for transcriptomics solutions is primarily fueled by the rising prevalence of chronic diseases, the surge in personalized medicine initiatives, and growing research in oncology, immunology, and neurobiology
- North America dominates the transcriptomics market with the largest revenue share of 38.5% in 2024, attributed to the region’s robust research infrastructure, strong funding support from government and private sectors, and widespread adoption of advanced sequencing technologies, with the U.S. leading in transcriptomics-based clinical and academic research
- Asia-Pacific is expected to be the fastest growing region with a CAGR of 13.4% in the transcriptomics market during the forecast period, driven by expanding biotechnology sectors, increasing government investments in genomics, and the rising number of clinical trials and pharmaceutical R&D activities in countries such as China, India, and South Korea
- The consumables segment dominates the transcriptomics market with a market share of 38.6% in 2024, primarily due to the high recurring demand for reagents, kits, and probes in transcriptomic workflows, particularly in large-scale gene expression studies and clinical diagnostics
Frequently Asked Questions
The market is segmented based on Segmentation, By Product and Services (Instruments, Consumables, Software, and Services), Technology (Microarray, Real Time-PCR (qPCR), and Sequencing), Application (Diagnostics and Disease Profiling, Drug Discovery, and Others), End User (Pharmaceutical and Biotechnology Companies, Government Institutes and Academic Centers, and Contract Research Organizations (CROs)) - Industry Trends and Forecast to 2032
.
The Global Transcriptomics Market size was valued at USD 8.37 USD Billion in 2024.
The Global Transcriptomics Market is projected to grow at a CAGR of 96.8% during the forecast period of 2025 to 2032.
The major players operating in the market include Agilent TechnologiesInc. , IlluminaInc. , F. Hoffmann-La Roche Ltd , Beckman CoulterInc. , Thermo Fisher Scientific Inc. , BD , Sartorius AG , BIOMÉRIEUX , Bio-Rad LaboratoriesInc. , Cepheid , Takara Bio Inc. , Cytognomix Inc. , GENERAL ELECTRIC COMPANY , Siemens , QIAGEN , Merck KGaA , AffiPCR , 10x Genomics , and Bruker Spatial BiologyInc. .
The market report covers data from the North America.
